Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Tenderness, Vaccination site pain, Vision blurred
Clinical narrative: lacrimal glands infection in left eye; Muscle aches specially in a previously injured muscle; Tenderness when pressure is applied; left arm diffuse pain/pain left arm when in use; left eye problem infection; No tear production; left eye problem, blurry vision/ film over my vision/having difficulties with the vision, like a film over patient's vision; Pain at injection site left arm; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PAIN IN EXTREMITY (left arm diffuse pain/pain left arm when in use), EYE INFECTION (left eye problem infection), DACRYOCANALICULITIS (lacrimal glands infection in left eye), LACRIMATION DECREASED (No tear production) and VISION BLURRED (left eye problem, blurry vision/ film over my vision/having difficulties with the vision, like a film over patient's vision) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 024C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 (COVID-19 positive before first dose.).    On 04-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-May-2021, the patient experienced VACCINATION SITE PAIN (Pain at injection site left arm). On 07-May-2021, the patient experienced EYE INFECTION (left eye problem infection), LACRIMATION DECREASED (No tear production) and VISION BLURRED (left eye problem, blurry vision/ film over my vision/having difficulties with the vision, like a film over patient's vision). On 11-May-2021, the patient experienced PAIN IN EXTREMITY (left arm diffuse pain/pain left arm when in use) and TENDERNESS (Tenderness when pressure is applied). On an unknown date, the patient experienced DACRYOCANALICULITIS (lacrimal glands infection in left eye) and MYALGIA (Muscle aches specially in a previously injured muscle). The patient was treated with NEOMYCIN for Adverse event, at an unspecified dose and frequency; POLYMYXIN ongoing since an unknown date for Adverse event, at an unspecified dose and frequency and DEXAMETHASONE, NEOMYCIN SULFATE, POLYMYXIN B SULFATE (MAXITROL) for Lacrimal duct infection, at an unspecified dose and frequency. On 05-May-2021, VACCINATION SITE PAIN (Pain at injection site left arm) had resolved. At the time of the report, PAIN IN EXTREMITY (left arm diffuse pain/pain left arm when in use), EYE INFECTION (left eye problem infection), DACRYOCANALICULITIS (lacrimal glands infection in left eye), LACRIMATION DECREASED (No tear production), VISION BLURRED (left eye problem, blurry vision/ film over my vision/having difficulties with the vision, like a film over patient's vision), TENDERNESS (Tenderness when pressure is applied) and MYALGIA (Muscle aches specially in a previously injured muscle) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported.  Other treatment medications included lowdose steroids.   Most recent FOLLOW-UP information incorporated above includes: On 14-May-2021: Follow-up received added new events treatment medication. On 25-May-2021: Follow-up received updated medical history and outcome of the events.